Molecular determinants of heart failure with normal left ventricular ejection fraction.
about
Heart failure with preserved ejection fraction: emerging drug strategiesBreakthrough in heart failure with preserved ejection fraction: are we there yet?Measuring passive myocardial stiffness in Drosophila melanogaster to investigate diastolic dysfunctionHeart Failure: a Major Cardiovascular Complication of Diabetes MellitusA Drosophila melanogaster model of diastolic dysfunction and cardiomyopathy based on impaired troponin-T function.Left ventricular remodeling and improvement in diastolic function after balloon aortic valvuloplasty for congenital aortic stenosis.Systems biology applied to heart failure with normal ejection fractionWhat we know and do not know about sex and cardiac disease.Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction.New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titinHeart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic Enigma.Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community.Modest overexpression of FOXO maintains cardiac proteostasis and ameliorates age-associated functional decline.Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β.Diastolic heart failure: a confusing concept.Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology.Heart Failure with Preserved Ejection Fraction in Older Adults.Myocardial reverse remodeling: how far can we rewind?A change of heart: oxidative stress in governing muscle function?Serum advanced glycation endproducts are associated with left ventricular dysfunction in normal glucose metabolism but not in type 2 diabetes: The Hoorn Study.Association of type 2 diabetes mellitus and ratio of transmitral E wave velocity to early diastole mitral velocity with cardiovascular events in chronic kidney disease.Type 2 diabetes mellitus-related changes in left ventricular structure and function in patients with chronic kidney disease.Characterization of oral squamous cell carcinoma based on higher-harmonic generation microscopy.Sustained cardiac remodeling after a short-term very low calorie diet in type 2 diabetes mellitus patients.
P2860
Q24595118-41B6D4B2-EFAB-4808-8EA7-D7EAE04E2859Q26771999-8507F0CD-7580-4BAE-88B8-560346E18597Q27015020-CF2A16F8-356D-4D52-99D1-672BBA5C802AQ28066310-6EEC03F2-E9EB-4CB4-B144-B2AAF788C565Q30660058-AE3E4AC4-44DD-4C02-851D-395B39FB54C3Q33647881-CBAAF37A-E121-473B-96AE-B9098400594EQ33733448-1B7797D0-D0EC-414F-AF68-3A0CAC0BE0DAQ33812503-19718855-E9DD-4085-9CD1-648A2B078722Q33913498-16012E33-D5CE-4DFA-B39D-28C7F93E0E31Q34375466-5B4403F1-9055-402A-BF62-86620907E473Q35026270-CF4383CE-0225-4A99-A9FE-D5E4B61E9B0CQ35328760-0734C61E-AC06-47D9-B415-FC57D2257764Q35536451-7C218CB6-E894-4B55-A5D6-ABA6DE2B95B6Q35671472-F5816A02-C4F5-450F-A03E-7688DE430FF9Q37592017-C0273336-A20E-4646-B2E3-A24D77B8689AQ37924999-22E21990-7792-472F-9B85-7E59D269979CQ38041989-A0C0CD47-797D-4888-88BA-6E054A4ACBB1Q38532386-41FB3255-BB92-46E8-914F-C18243C43A12Q38672337-7910675A-936B-4804-ADF0-24B6ECCF9823Q38780883-78344C08-C452-46C4-872B-AE569FD580BBQ39310989-605B3A2F-005B-4333-8481-7F28CBA6617AQ40749360-84578F86-356F-4AC4-AC20-D07718C14F66Q47114042-7B1C5968-063F-484F-96EE-236F36BAED58Q51244376-09F36CD3-44C0-46AE-9A1B-E35E5793B2AEQ51392621-6777A814-3EE8-407B-AA96-3A35AA742635Q54753340-79C82A01-FE8C-471D-A8B9-67D7152DCF7B
P2860
Molecular determinants of heart failure with normal left ventricular ejection fraction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular determinants of heart failure with normal left ventricular ejection fraction.
@en
Molecular determinants of heart failure with normal left ventricular ejection fraction.
@nl
type
label
Molecular determinants of heart failure with normal left ventricular ejection fraction.
@en
Molecular determinants of heart failure with normal left ventricular ejection fraction.
@nl
prefLabel
Molecular determinants of heart failure with normal left ventricular ejection fraction.
@en
Molecular determinants of heart failure with normal left ventricular ejection fraction.
@nl
P2093
P1476
Molecular determinants of heart failure with normal left ventricular ejection fraction.
@en
P2093
Attila Borbély
István Edes
Walter J Paulus
Zoltán Papp
P304
P356
10.1016/S1734-1140(09)70016-7
P577
2009-01-01T00:00:00Z